EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism


New England Journal of Medicine 314(16): 1015-1020
Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism
Hyporeninemic hypoaldosteronism is an important cause of hyperkalemia and is characterized by low renin secretion. We found that prostacyclin, a potent vasodilator and renin secretagogue, was markedly reduced--as reflected by its stable urinary metabolite 6-keto-prostaglandin F1 alpha--in seven patients with hyporeninemic hypoaldosteronism as compared with seven matched controls with renal insufficiency and as compared with 12 normal volunteers (mean +/- SE, 42 +/- 7 vs. 185 +/- 37 and 164 +/- 20 ng per gram of creatinine, respectively; P less than 0.001). In contrast, renal prostaglandin E2 excretion was similar in all three groups. A low-dose infusion of calcium or norepinephrine (known stimulants of prostacyclin) increased renal prostacyclin release in normal subjects and controls with renal insufficiency. Neither agonist, however, increased the low basal prostacyclin excretion in the patients (49.6 +/- 11 [basal] vs. 62 +/- 20 [norepinephrine] and 47.5 +/- 16 [calcium]; P greater than 0.8). To evaluate the functional importance of the altered prostacyclin production, we studied the responses of renal blood flow and blood pressure to the calcium infusion. The calcium infusion did not alter blood pressure or renal blood flow in the normal subjects or the controls with renal insufficiency. In contrast, the same dose of calcium in the patients with hyporeninemic hypoaldosteronism produced a rise in mean blood pressure (from 91 +/- 6 to 104 +/- 8 mm Hg, P less than 0.05) and a fall in renal blood flow (from 673 +/- 58 to 560 +/- 42 ml per minute per 1.73 m2, P less than 0.05). These results indicate that a deficiency of prostacyclin could explain the low active-renin concentration and altered vasomotor tone seen in hyporeninemic hypoaldosteronism.


Accession: 005411678

PMID: 3515183

DOI: 10.1056/NEJM198604173141604



Related references

Evidence for prostacyclin deficiency in hyporeninemic hypoaldosteronism. Clinical Research: 98a, 1985

Hyporeninemic hypoaldosteronism a prostacyclin deficiency. Clinical Researchpart 1: 587a, 1985

Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. American Journal of Medicine 82(5): 1035-1038, 1987

Stimulation of the renin-aldosterone system by prostacyclin infusion in hyporeninemic hypoaldosteronism. Medizinische Klinik 83(8-9): 289-291, 1988

A case of isolated ACTH deficiency with hyporeninemic hypoaldosteronism. Nephron 73(2): 301-304, 1996

The syndrome of hyporeninemic hypoaldosteronism. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 83(6): 585-591, 1984

The syndrome of hyporeninemic hypoaldosteronism. Annual Review of Medicine 30: 145-153, 1979

Pseudo-Addison's disease. Isolated corticotropin deficiency associated with hyporeninemic hypoaldosteronism. Archives of Internal Medicine 146(5): 996-997, 1986

Pseudo addisons disease isolated corticotropin deficiency associated with hyporeninemic hypoaldosteronism. 1986

Hyporeninemic hypoaldosteronism associated with Sjogrens syndrome. American Journal of Medicine 112(3): 245-246, February 15, 2002